Skip to Content
Merck
  • p-Sulfonato-calix[n]arenes inhibit staphylococcal bicomponent leukotoxins by supramolecular interactions.

p-Sulfonato-calix[n]arenes inhibit staphylococcal bicomponent leukotoxins by supramolecular interactions.

The Biochemical journal (2013-01-04)
Benoît-Joseph Laventie, Cristina Potrich, Cédric Atmanène, Maher Saleh, Olivier Joubert, Gabriella Viero, Christoph Bachmeyer, Valeria Antonini, Ines Mancini, Sarah Cianferani-Sanglier, Daniel Keller, Didier A Colin, Tristan Bourcier, Gregor Anderluh, Alain van Dorsselaer, Mauro Dalla Serra, Gilles Prévost
ABSTRACT

PVL (Panton-Valentine leukocidin) and other Staphylococcus aureus β-stranded pore-forming toxins are important virulence factors involved in various pathologies that are often necrotizing. The present study characterized leukotoxin inhibition by selected SCns (p-sulfonato-calix[n]arenes): SC4, SC6 and SC8. These chemicals have no toxic effects on human erythrocytes or neutrophils, and some are able to inhibit both the activity of and the cell lysis by leukotoxins in a dose-dependent manner. Depending on the type of leukotoxins and SCns, flow cytometry revealed IC50 values of 6-22 μM for Ca2+ activation and of 2-50 μM for cell lysis. SCns were observed to affect membrane binding of class S proteins responsible for cell specificity. Electrospray MS and surface plasmon resonance established supramolecular interactions (1:1 stoichiometry) between SCns and class S proteins in solution, but not class F proteins. The membrane-binding affinity of S proteins was Kd=0.07-6.2 nM. The binding ability was completely abolished by SCns at different concentrations according to the number of benzenes (30-300 μM; SC8>SC6≫SC4). The inhibitory properties of SCns were also observed in vivo in a rabbit model of PVL-induced endophthalmitis. These calixarenes may represent new therapeutic avenues aimed at minimizing inflammatory reactions and necrosis due to certain virulence factors.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Sphingomyelinase from Staphylococcus aureus, buffered aqueous glycerol solution, 100-300 units/mg protein (Lowry)
Sigma-Aldrich
Sphingomyelinase from Bacillus cereus, buffered aqueous glycerol solution, ≥100 units/mg protein (Lowry)
Sigma-Aldrich
Sphingomyelinase from Bacillus cereus, lyophilized powder, ≥100 units/mg protein